Course offering number:0805-701
Course ID:
2198
Evolution of the Pharmaceutical Industry through 2020
Pre-recorded Course
AN ON-DEMAND ONLINE TRAINING FORMAT
Who Should Attend
This course incorporates multiphase views of conventional, biologic and generic drug sectors. Each of these sectors will impact the others significantly over the next decade - and all have drastic importance to capital markets, stockholders, legislators and the patient. Understanding these trends is vital for anyone that plans to conduct pharma business over the next fifteen years. It is recommended for:-
Pharmaceutical business planners
- Quality Risk Managers
- Human resources–both employers and the employed
- Drug pipeline candidate evaluators
- Pharmaceutical sales, distribution and marketing personnel
- Investors, stockholders and business valuers
Description
This highly focused 90 minute accredited course provides a top-level overview of drug-product R&D strategies, merger
alternatives, legislative and consumer impact, timelines and cycles that will affect capital costs and revenue
streams, change in drug portfolios and the concomitant changes in patient acceptance. The course points
out strategic pathways for managing in an evolutionary operating model.
For Detailed Course Outline download PDF brochure